Latest Articles

Article Type

You have access
Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the α2β3γ2 GABA-A Receptor
Brandon Pressly, Ruth D. Lee, Bogdan Barnych, Bruce D. Hammock and Heike Wulff

Molecular Pharmacology October 27, 2020, MOLPHARM-AR-2020-000090; DOI: https://doi.org/10.1124/molpharm.120.000090
You have access
Antiepileptic Drug–Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator–Activated Receptor α and Peroxisome Proliferator–Activated Receptor γ Coactivator 1α–Dependent Gene Expression to Increase Blood Triglyceride Levels
Ryota Shizu, Yuta Otsuka, Kanako Ezaki, Chizuru Ishii, Shingo Arakawa, Yuto Amaike, Taiki Abe, Takuomi Hosaka, Takamitsu Sasaki, Yuichiro Kanno, Masaaki Miyata, Yasushi Yamazoe and Kouichi Yoshinari

Molecular Pharmacology November 2020, 98 (5) 634-647; DOI: https://doi.org/10.1124/molpharm.120.000103
You have access
Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection
Omid Tavassoly, Farinaz Safavi and Iman Tavassoly

Molecular Pharmacology November 2020, 98 (5) 612-619; DOI: https://doi.org/10.1124/molpharm.120.000098
Open Access
Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias
Elsa Martins, Hellena Brodier, Irène Rossitto-Borlat, Ilke Ilgaz, Mélanie Villard and Oliver Hartley

Molecular Pharmacology November 2020, 98 (5) 599-611; DOI: https://doi.org/10.1124/molpharm.120.000036
You have access
Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme
Elzbieta Janda, Françoise Nepveu, Barbara Calamini, Gilles Ferry and Jean A. Boutin

Molecular Pharmacology November 2020, 98 (5) 620-633; DOI: https://doi.org/10.1124/molpharm.120.000105
You have access
Dysregulation of ACE2 Expression and Function in Co-morbid Disease Conditions Possibly Contributes to COVID-19 Complication Severity
Safaa Hammoud, Zena Wehbe, Samar Abdelhady, Firas Kobeissy, Ali Hussein Eid and Ahmed F El-Yazbi

Molecular Pharmacology October 20, 2020, MOLPHARM-MR-2020-000119; DOI: https://doi.org/10.1124/molpharm.120.000119
You have access
Correction to “Commentary on: Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”
Molecular Pharmacology November 2020, 98 (5) 598; DOI: https://doi.org/10.1124/molpharm.120.000049err
You have access
The influence of tobacco smoke/nicotine on CYP2A expression in Human and African Green Monkey Lungs
Yuan Gao, Sharon Miksys, Roberta M Palmour and Rachel F. Tyndale

Molecular Pharmacology October 14, 2020, MOLPHARM-AR-2020-000100; DOI: https://doi.org/10.1124/molpharm.120.000100
You have access
Glutamate, AP5 and NMDA do not directly modulate glycine receptors
Karin R. Aubrey, Diba Sheipouri, Thomas Balle, Robert J. Vandenberg and Yo Otsu

Molecular Pharmacology October 13, 2020, MOLPHARM-AR-2020-000127; DOI: https://doi.org/10.1124/molpharm.120.000127
You have access
MicroRNA-1291-5p sensitizes pancreatic carcinoma cells to arginine deprivation and chemotherapy through the regulation of arginolysis and glycolysis
Mei-Juan Tu, Zhijian Duan, Zhenzhen Liu, Chao Zhang, Richard J. Bold, Frank J. Gonzalez, Edward J. Kim and Ai-Ming Yu

Molecular Pharmacology October 13, 2020, MOLPHARM-AR-2020-000130; DOI: https://doi.org/10.1124/molpharm.120.000130

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals